There are studies suggesting that EZH2 probably plays an important role in carcinogenesis of breast carcinoma [10–18], and high expression of EZH2 was associated with triple-negative breast carcinoma [15, 16, 18–21]. Here, EZH2 is linked to triple-negative breast carcinoma.